These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3311549)

  • 1. Calcium channel blocker drugs and diabetic control.
    Collins WC; Cullen MJ; Feely J
    Clin Pharmacol Ther; 1987 Oct; 42(4):420-3. PubMed ID: 3311549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
    Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
    Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
    Jasik M; Kasperska-Dworak A; Czyzyk A
    Diabetes Res Clin Pract; 1996 Jun; 33(1):59-66. PubMed ID: 8877277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Giordano M; Sanders LR; Castellino P; Canessa ML; DeFronzo RA
    Nephron; 1996; 72(3):447-53. PubMed ID: 8852495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium channel blockers and hydralazine on epinephrine-induced hyperglycemia in vivo.
    Ogihara M
    Jpn J Pharmacol; 1989 Jun; 50(2):141-7. PubMed ID: 2770052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the calcium channel blocker nilvadipine on urinary albumin excretion in hypertensive microalbuminuric patients with non-insulin-dependent diabetes mellitus.
    Sumida Y; Yano Y; Murata K; Goto H; Ura H; Ezaki J; Tsutsumi S; Shirayama K; Misaki M; Shima T
    J Int Med Res; 1997; 25(3):117-26. PubMed ID: 9178143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium channel blockers and hydralazine on plasma glucose levels in streptozotocin-induced diabetic rats in vivo.
    Sunaga K; Ogihara M
    Jpn J Pharmacol; 1990 Mar; 52(3):449-55. PubMed ID: 2332939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of a calcium channel blocker, nicardipine, on glucoregulatory hormones and glucose metabolism].
    Tanioka F; Ishihara H; Kotani N; Sakai T; Kudo M; Matsuki A; Oyama T
    Masui; 1986 Jan; 35(1):78-83. PubMed ID: 3520039
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
    Sasaki H; Naka K; Kishi Y; Ohoshi T; Hagihara T; Matsuo H; Sowa R; Matsumoto G; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1994 Nov; 26(1):67-75. PubMed ID: 7533075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
    Matsumoto H; Noji I; Akimoto Y; Fujii A
    J Oral Sci; 2001 Dec; 43(4):261-8. PubMed ID: 11848193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
    Cleophas TJ; van Ouwerkerk BM; van der Meulen J; Zwinderman AH
    Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent effects of nicardipine and captopril on urinary albumin excretion of type 2, non-insulin-dependent diabetic subjects with mild to moderate hypertension.
    Bouhanick B
    Therapie; 1996; 51(1):41-7. PubMed ID: 8762219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in stable effort angina.
    Di Pasquale G; Lusa AM; Manini GL; Coluccini M; Bassein L; Pinelli G
    Int J Cardiol; 1984 Dec; 6(6):673-88. PubMed ID: 6519841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of calcium-blockers nicardipine, darodipine, PN-200-110 and nifedipine on insulin release from isolated rat pancreatic islets.
    Al-Mahmood HA; el-Khatim MS; Gumaa KA; Thulesius O
    Acta Physiol Scand; 1986 Feb; 126(2):295-8. PubMed ID: 2939690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Chest; 1986 Feb; 89(2):260-5. PubMed ID: 3510823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
    Klauser R; Speiser P; Gisinger C; Schernthaner G; Prager R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S93-6. PubMed ID: 1695314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of enalapril and nifedipine in diabetic hypertensives.
    Andronico G; Angileri G; Piazza G; Cerasola G
    J Hypertens Suppl; 1991 Dec; 9(6):S408-9. PubMed ID: 1819007
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of nicardipine on glucose and drug-stimulated insulin secretion in normal volunteers.
    Dow RJ; Baty J; Isles TE
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):75S-83S. PubMed ID: 3896283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.